Trials / Unknown
UnknownNCT01101256
Determination of Residual Anticoagulatory Effects of Fondaparinux
Determination of Residual Anticoagulatory Effects of Prophylactic or Therapeutic Treatment With Fondaparinux
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (estimated)
- Sponsor
- Johann Wolfgang Goethe University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine residual anticoagulatory effects of a prophylactic or therapeutic fondaparinux treatment i.e. prior to surgery/intervention, after pause of therapy etc.
Conditions
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-09-01
- Completion
- 2010-10-01
- First posted
- 2010-04-09
- Last updated
- 2010-04-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01101256. Inclusion in this directory is not an endorsement.